HK1255014A1 - 制备取代5,6-二氢-6-苯基苯并[f]异喹啉-2-胺的方法 - Google Patents

制备取代5,6-二氢-6-苯基苯并[f]异喹啉-2-胺的方法 Download PDF

Info

Publication number
HK1255014A1
HK1255014A1 HK18114135.7A HK18114135A HK1255014A1 HK 1255014 A1 HK1255014 A1 HK 1255014A1 HK 18114135 A HK18114135 A HK 18114135A HK 1255014 A1 HK1255014 A1 HK 1255014A1
Authority
HK
Hong Kong
Prior art keywords
methods
phenylbenzo
isoquinolin
dihydro
amine
Prior art date
Application number
HK18114135.7A
Other languages
English (en)
Chinese (zh)
Inventor
Craig Bates
David P. Reed
Jianmin Mao
Original Assignee
Arqule, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Arqule, Inc. filed Critical Arqule, Inc.
Publication of HK1255014A1 publication Critical patent/HK1255014A1/zh

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72Quinazolines; Hydrogenated quinazolines
    • C07D239/78Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 2
    • C07D239/84Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/517Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07Optical isomers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
HK18114135.7A 2015-12-17 2016-12-16 制备取代5,6-二氢-6-苯基苯并[f]异喹啉-2-胺的方法 HK1255014A1 (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562268758P 2015-12-17 2015-12-17
US62/268,758 2015-12-17
PCT/US2016/067161 WO2017106639A1 (en) 2015-12-17 2016-12-16 Methods for preparing substituted 5,6-dihydro-6-phenylbenzo[f]isoquinolin-2-amine

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
HK42022065737.3A Division HK40079039A (en) 2015-12-17 2018-11-06 Methods for preparing substituted 5,6-dihydro-6-phenylbenzo[f]isoquinolin-2-amine

Related Child Applications (1)

Application Number Title Priority Date Filing Date
HK42022065737.3A Addition HK40079039A (en) 2015-12-17 2018-11-06 Methods for preparing substituted 5,6-dihydro-6-phenylbenzo[f]isoquinolin-2-amine

Publications (1)

Publication Number Publication Date
HK1255014A1 true HK1255014A1 (zh) 2019-08-02

Family

ID=59057623

Family Applications (1)

Application Number Title Priority Date Filing Date
HK18114135.7A HK1255014A1 (zh) 2015-12-17 2016-12-16 制备取代5,6-二氢-6-苯基苯并[f]异喹啉-2-胺的方法

Country Status (16)

Country Link
US (4) US9834519B2 (https=)
EP (2) EP4015508A1 (https=)
JP (2) JP6940504B2 (https=)
KR (1) KR20180085814A (https=)
CN (2) CN108602779A (https=)
AU (2) AU2016369520B2 (https=)
BR (1) BR112018012325A2 (https=)
CA (1) CA3006077A1 (https=)
EA (1) EA201891431A1 (https=)
HK (1) HK1255014A1 (https=)
IL (1) IL259557A (https=)
MX (2) MX2020012771A (https=)
NZ (1) NZ742785A (https=)
SG (1) SG11201804601TA (https=)
TW (1) TWI748972B (https=)
WO (1) WO2017106639A1 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG11201804601TA (en) * 2015-12-17 2018-07-30 Arqule Inc Methods for preparing substituted 5,6-dihydro-6-phenylbenzo[f]isoquinolin-2-amine
EA036295B1 (ru) 2015-12-17 2020-10-22 Аркьюл, Инк. Твердые формы замещенных 5,6-дигидро-6-фенилбензо[f]изохинолин-2-аминовых соединений
CN110669015A (zh) * 2018-07-03 2020-01-10 上海喀露蓝科技有限公司 一种fgfr抑制剂的制备方法
US10878412B2 (en) * 2019-05-13 2020-12-29 Truist Bank In-line verification of transactions
WO2022053708A1 (en) 2020-09-14 2022-03-17 Basilea Pharmaceutica International AG Pharmaceutical combinations for use in the treatment of gastric adenocarcinoma

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4522811A (en) 1982-07-08 1985-06-11 Syntex (U.S.A.) Inc. Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
US6057329A (en) * 1996-12-23 2000-05-02 Celltech Therapeutics Limited Fused polycyclic 2-aminopyrimidine derivatives
GB9713087D0 (en) * 1997-06-20 1997-08-27 Celltech Therapeutics Ltd Chemical compounds
US7786132B2 (en) * 2004-12-17 2010-08-31 Amgen Inc. Aminopyrimidine compounds and methods of use
EP2079736B1 (en) 2006-12-29 2017-10-18 Rigel Pharmaceuticals, Inc. Substituted triazoles useful as axl inhibitors
GB2449293A (en) * 2007-05-17 2008-11-19 Evotec Compounds having Hsp90 inhibitory activity
TWI461410B (zh) * 2008-12-30 2014-11-21 Arqule Inc 經取代之5,6-二氫-6-苯基苯並〔f〕異喹啉-2-胺化合物類
CN103476770B (zh) 2010-11-25 2017-02-15 拉蒂欧制药有限责任公司 阿法替尼盐和多晶型物
US8815854B2 (en) 2011-06-24 2014-08-26 Arqule, Inc. Substituted imidazopyridinyl compounds
SG11201607772WA (en) * 2014-03-31 2016-10-28 Debiopharm Int Sa Fgfr fusions
SG11201804601TA (en) * 2015-12-17 2018-07-30 Arqule Inc Methods for preparing substituted 5,6-dihydro-6-phenylbenzo[f]isoquinolin-2-amine
EA036295B1 (ru) 2015-12-17 2020-10-22 Аркьюл, Инк. Твердые формы замещенных 5,6-дигидро-6-фенилбензо[f]изохинолин-2-аминовых соединений

Also Published As

Publication number Publication date
CN114874149A (zh) 2022-08-09
BR112018012325A2 (pt) 2018-12-04
US20200102276A1 (en) 2020-04-02
NZ742785A (en) 2023-06-30
KR20180085814A (ko) 2018-07-27
AU2021202610B2 (en) 2022-06-02
WO2017106639A1 (en) 2017-06-22
US10093632B2 (en) 2018-10-09
US20180065937A1 (en) 2018-03-08
CA3006077A1 (en) 2017-06-22
IL259557A (en) 2018-07-31
JP2018537495A (ja) 2018-12-20
US10766868B2 (en) 2020-09-08
US9834519B2 (en) 2017-12-05
AU2016369520B2 (en) 2021-02-18
MX385672B (es) 2025-03-18
TWI748972B (zh) 2021-12-11
AU2016369520A1 (en) 2018-06-07
SG11201804601TA (en) 2018-07-30
US20170174637A1 (en) 2017-06-22
AU2021202610A1 (en) 2021-05-27
MX2020012771A (es) 2022-10-04
MX2018007415A (es) 2018-11-09
JP2021191782A (ja) 2021-12-16
EP4015508A1 (en) 2022-06-22
US20190241527A1 (en) 2019-08-08
TW201733992A (zh) 2017-10-01
US11279679B2 (en) 2022-03-22
EP3390368A1 (en) 2018-10-24
EP3390368A4 (en) 2019-07-03
CN108602779A (zh) 2018-09-28
JP6940504B2 (ja) 2021-09-29
EA201891431A1 (ru) 2018-11-30

Similar Documents

Publication Publication Date Title
ZA201907687B (en) Salt of an aminopyridine derivative compound, a crystalline form thereof, and a process for preparing the same
WO2016071435A3 (en) Synthesis of copanlisib and its dihydrochloride salt
HK1263287A1 (zh) 抗真菌化合物和制备方法
EP3275883A4 (en) Method for producing novel nitrogen-containing compound or salt thereof, and production intermediate of same
EP3231805A4 (en) Salt of pyrrolo[2,3-d]pyrimidine compound and novel polymorph of salt
MY183123A (en) Synthesis of copanlisib and its di hydrochloride salt
WO2014141292A3 (en) Endoxifen citrate polymorph and process for preparing the same
HK1255014A1 (zh) 制备取代5,6-二氢-6-苯基苯并[f]异喹啉-2-胺的方法
WO2015068175A3 (en) An improved process for the preparation of pazopanib or a pharmaceutically acceptable salt thereof
PT3619199T (pt) Preparação de derivados de ácido 2-([1,2,3]triazol-2-il)- benzoico
EP3369733A4 (en) Crystal form of 4h-pyrazolo[1,5- ]benzoimidazole compound, preparation method therefor and intermediate thereof
EP3353149A4 (en) PROCESS FOR THE PREPARATION OF INDOLIN COMPOUNDS AND A NOVEL INDOLIN SALT
PT3398946T (pt) Sal de derivado de morfolina e a sua forma cristalina, bem como método de preparação, composição farmacêutica e a sua utilização
EP3118207A4 (en) Inclusion compound of 3',5'-cyclicdiadenylic acid, and method for producing same
EP2997009A4 (en) Process for the preparation of arformoterol or salt thereof
IL258451A (en) Salt type and crystal type of h4-pyrazole [5,1-alpha] compound benzimidazole and its method of preparation and intermediate
WO2017046816A3 (en) Process for the preparation of derivatives of benzodioxole
WO2015104602A3 (en) A process for the preparation of anagliptin and its intermediates thereof
WO2015001568A3 (en) Sitagliptin lipoate salt, process for the preparation and pharmaceutical composition thereof
WO2014136062A3 (en) Process for the preparation of deferasirox
EP3177592A4 (en) Process for the preparation of 4,5,6-trichloropicolinic acid
HK1247196A1 (zh) Scy-078的新型盐及多晶型物
HUP1800089A2 (en) Process for the preparation of the b polymorph form of treprostinil-diethanol-amine salt
HK1255019A1 (en) Solid forms of substituted 5,6-dihydro-6-phenylbenzo[f]isoquinolin-2-amine compounds
IN2014CH01257A (https=)